The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.
Timothy M. Ring net worth and biography

Timothy Ring Biography and Net Worth

Director of Quest Diagnostics
Timothy M. Ring serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Ring has been a member of the board since 2017, previously serving as chairman and chief executive officer of C. R. Bard, Inc. from 2003 to 2017.

Ring also is lead director of Quest Diagnostics Incorporated, and a co-founder of TEAMFund, Inc., an impact fund focused on delivering medical technology to sub-Saharan Africa and India.

With over 20 years of experience in various leadership positions at Bard, Ring offers a unique perspective on the Bard business. As an experienced chief executive officer of a public company, Ring also contributes expertise in many facets of business, including strategy, product development and international operations, and has extensive experience in the healthcare industry.

What is Timothy M. Ring's net worth?

The estimated net worth of Timothy M. Ring is at least $3.52 million as of December 1st, 2022. Mr. Ring owns 24,149 shares of Quest Diagnostics stock worth more than $3,516,819 as of January 29th. This net worth evaluation does not reflect any other investments that Mr. Ring may own. Learn More about Timothy M. Ring's net worth.

How do I contact Timothy M. Ring?

The corporate mailing address for Mr. Ring and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected] Learn More on Timothy M. Ring's contact information.

Has Timothy M. Ring been buying or selling shares of Quest Diagnostics?

Timothy M. Ring has not been actively trading shares of Quest Diagnostics during the last quarter. Most recently, Timothy M. Ring sold 2,025 shares of the business's stock in a transaction on Thursday, December 1st. The shares were sold at an average price of $152.50, for a transaction totalling $308,812.50. Following the completion of the sale, the director now directly owns 24,149 shares of the company's stock, valued at $3,682,722.50. Learn More on Timothy M. Ring's trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes Michael Deppe (CAO), Catherine Doherty (SVP), Mark Guinan (CFO), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 11 times. They sold a total of 408,277 shares worth more than $57,554,473.92. The most recent insider tranaction occured on December, 1st when Director Timothy M Ring sold 2,025 shares worth more than $308,812.50. Insiders at Quest Diagnostics own 1.7% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 12/1/2022.

Timothy M. Ring Insider Trading History at Quest Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2022Sell2,025$152.50$308,812.5024,149View SEC Filing Icon  
11/1/2022Sell2,000$144.06$288,120.0024,149View SEC Filing Icon  
10/3/2022Sell2,000$123.39$246,780.0023,933View SEC Filing Icon  
8/1/2022Sell2,000$136.04$272,080.0023,933View SEC Filing Icon  
7/1/2022Sell2,000$133.47$266,940.0023,933View SEC Filing Icon  
See Full Table

Timothy M. Ring Buying and Selling Activity at Quest Diagnostics

This chart shows Timothy M Ring's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Read More

Today's Range

Now: $145.63
Low: $145.21
High: $147.33

50 Day Range

MA: $150.60
Low: $143.90
High: $157.28

2 Week Range

Now: $145.63
Low: $120.40
High: $158.34

Volume

1,025,201 shs

Average Volume

923,609 shs

Market Capitalization

$16.59 billion

P/E Ratio

14.32

Dividend Yield

1.81%

Beta

0.98
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.